Substance / Medication

Ethanolamine

Overview

Active Ingredient
ethanolamine
RxNorm CUI
24457

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Phosphatidylethanolamine N-methyltransferase gene rs7946 polymorphism plays a role in risk of nonalcoholic fatty liver disease: evidence from meta-analysis.
Tan Hwa-Li, Mohamed Rosmawati, Mohamed Zahurin et al. · Pharmacogenet Genomics · 2016
PMID: 26636496Meta-Analysis
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking.
Mennella Ilario, Di Monaco Rossella, Balazy Adriana et al. · Food Funct · 2018
PMID: 29235594RCT
Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea.
Tartaglia Edoardo, Armentano Mario, Giugliano Brunella et al. · J Pediatr Adolesc Gynecol · 2015
PMID: 26233289RCT
[Studies on spray of niclosamide ethanolamine salt II observation on prevention of Schistosoma japonicum infection in bovine].
Dai Jian-Rong, Xing Yun-Tian, Li Hong-Jun et al. · Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi · 2012
PMID: 23593829RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ethanolamine (substance)
SNOMED CT
115589000
UMLS CUI
C0059696
RxNorm CUI
24457

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

1
Conditions
1
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.